Medical News

RSS

Plant-based diets could reduce the chances of disease progression in men with prostate cancer

Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil, according to new research by UC San Francisco.

13 May 2024

Plant virus-derived treatment shows promise against metastatic cancers

An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study from the University of California San Diego.

13 May 2024

Aficamten shows promise in enhancing exercise capacity in patients with hypertrophic cardiomyopathy

Even though mortality and hospitalization rates have improved, the quality of life for those living with hypertrophic cardiomyopathy (HCM) can be compromised with limiting symptoms such as exertional dyspnoea and decreased exercise capacity.

13 May 2024

Research unlocks the role of macrophages in cancer relapse

Researchers from the Cancer Science Institute of Singapore at the National University of Singapore (NUS), have achieved breakthroughs in understanding relapse after chemotherapy for a type of cancer known as diffuse large B-cell lymphoma (DLBCL).

13 May 2024

Pioneering regulatory measures in China prove effective in reducing children's sedentary behavior

Pioneering measures to tackle sedentary behavior among children in China have proved effective, according to new research.

13 May 2024

Study reveals sharp surge in illicit fentanyl seizures

The number of illicit fentanyl seizures by law enforcement in the United States grew by more than 1,700 percent between 2017 and 2023, according to a new analysis.

13 May 2024

Landmark study sheds new light on the heterogeneity of type 2 diabetes

A landmark study by the DZD, published in 'The Lancet Diabetes & Endocrinology', sheds new light on the heterogeneity of type 2 diabetes.

13 May 2024

Semaglutide improves heart failure symptoms and reduces loop diuretic dose

Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF) regardless of diuretic use, according to late breaking research presented today at Heart Failure 2024, a scientific congress of the European Society of Cardiology.

13 May 2024

SHINE trial reveals risks of high blood sugar in post-thrombolysis stroke care

An ambitious, nationwide clinical trial led by UVA Health's Karen Johnston, MD, has provided doctors with long-needed insights into the importance of managing stroke patients' blood sugar after treatment with clot-busting therapy.

13 May 2024

Measles vaccine more likely to be completely ineffective in children born by C-section

A study by the University of Cambridge, UK, and Fudan University, China, has found that a single dose of the measles jab is up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally.

13 May 2024

Study shows limited effectiveness of common local anesthetic

Liposomal bupivacaine was launched on the market twelve years ago to provide long-lasting local control of pain.

13 May 2024

Uncovering the psychological toll of entrenched school practices on children

Many programs 'deeply entrenched in school culture' are harmful to children and can cause potentially lasting damage, psychologists have warned.

13 May 2024

Study reveals latest cancer trends in Canada

The number of cancer cases and deaths in Canada is expected to increase because of a growing and aging population, but the overall rates of people being diagnosed with and dying from cancer will continue to decline, according to the latest cancer trends research in CMAJ.

13 May 2024

FDA said it never inspected dental lab that made controversial AGGA device

The FDA never inspected Johns Dental Laboratories during more than a decade in which it made the Anterior Growth Guidance Appliance, or "AGGA," a dental device that has allegedly harmed patients and is now the subject of a criminal investigation.

13 May 2024

New insights into Chaga mushroom's mechanisms for fighting oral cancer

The mechanisms behind the anti-tumor activity of Chaga mushroom extracts in HSC-4 human oral cancer cells.

13 May 2024

Wearable biosensors with skin interfaces for newborn and neonatal health monitoring

Recent improvements in newborn wearable systems, concentrating on skin-interfaced wearables for physiological monitoring across many branches.

13 May 2024

San Francisco tries tough love by tying welfare to drug rehab

Raymond Llano carries a plastic bag with everything he owns in one hand, a cup of coffee in the other, and the flattened cardboard box he uses as a bed under his arm as he waits in line for lunch at Glide Memorial Church in San Francisco. At 55, he hasn't had a home for 15 years, since he lost a job at Target.

13 May 2024

First responders, veterans hail benefits of psychedelic drugs as California debates legalization

Wade Trammell recalls the time he and his fellow firefighters responded to a highway crash in which a beer truck rammed into a pole, propelling the truck's engine through the cab and into the driver's abdomen.

13 May 2024

ArgusEye closes €2.8 million funding to accelerate bioprocessing

ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB).

From ArgusEye AB 13 May 2024

ERS Genomics appoints John E Milad as Chief Executive Officer

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences and medical technology sectors.

From ERS Genomics 13 May 2024